Related Experiment Video
Updated: Feb 1, 2026

10:44
Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
29.8K
Annexins in Influenza Virus Replication and Pathogenesis
Patrick Baah Ampomah1, Wan Ting Kong1, Olga Zharkova1
1Department of Physiology, NUS Immunology Program, Centre for Life Sciences, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Frontiers in Pharmacology
|December 1, 2018
Summary
Influenza A virus (IAV) infections cause severe respiratory illness. Annexins (ANXs), particularly ANXA1, show promise as therapeutic targets for developing new antiviral treatments against IAV evasion.
Area of Science:
- Virology and Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- Influenza A viruses (IAVs) are significant human respiratory pathogens responsible for seasonal and pandemic infections.
- IAV infections can lead to severe complications such as pneumonia and acute respiratory distress syndrome.
- Viral evasion of host immunity via antigenic drift and shift necessitates novel therapeutic strategies.
Purpose of the Study:
- To review current research on Annexins (ANXs) and their role in modulating Influenza A virus infections.
- To highlight the potential of ANXs, specifically ANXA1, as therapeutic targets for IAV.
- To provide a comprehensive understanding of ANXs in host immune responses to IAV.
Main Methods:
- Literature review synthesizing recent findings on Annexins and IAV.
- Analysis of immunomodulatory roles of ANXs in viral infections and inflammation.
- Focus on ANXA1's interaction with IAV and host defense mechanisms.
Main Results:
- Annexins are calcium and phospholipid-binding proteins with established immunomodulatory functions.
- Evidence suggests ANXs play a role in regulating host responses during viral infections, including IAV.
- ANXA1 is identified as a key Annexin involved in modulating IAV pathogenesis and host immunity.
Conclusions:
- Understanding the role of Annexins in IAV infection is crucial for developing effective antiviral therapies.
- Annexins, particularly ANXA1, represent a promising target for novel anti-IAV treatment strategies.
- Further research into ANX-IAV interactions can lead to improved management of influenza.
Related Concept Videos
What are Viruses?
128.1K
Overview
128.1K
Chromosome Replication
10.6K
Before a cell can divide, it must accurately replicate all of its chromosomes, including the DNA and its associated histone and non-histone proteins. This process begins at numerous origins of replication during the S phase of the cell cycle in each of a cell’s chromosomes simultaneously. Certain nucleotides can act as origins of replication, but these sequences are not well defined - especially in complex, multi-cellular, eukaryotic species. The length of DNA that spans an origin...
10.6K
DNA Replication
59.3K
DNA replication involves the separation of the two strands of the double helix, with each strand serving as a template from which the new complementary strand is copied. After replication, each double-stranded DNA includes one parental or “old” strand and one “new” strand. This is known as semiconservative replication. The resulting DNA molecules have the same sequence and are divided equally into the two daughter cells.
Replication in Prokaryotes
DNA replication...
Replication in Prokaryotes
DNA replication...
59.3K
Replication in Prokaryotes
98.0K
Overview
98.0K
Replication in Eukaryotes
204.8K
Overview
204.8K
The DNA Replication Fork
41.0K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork. Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
41.0K

